# Posaconazole Prophylaxis for CAPA Prevention in Critically-Ill Patients

> **NCT05065658** · — · COMPLETED · sponsor: **Medical University of Graz** · enrollment: 249 (actual)

## Conditions studied

- COVID-19 Respiratory Infection
- Aspergillosis

## Interventions

- **DRUG:** Posaconazole

## Key facts

- **NCT ID:** NCT05065658
- **Lead sponsor:** Medical University of Graz
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-01
- **Primary completion:** 2023-08-23
- **Final completion:** 2023-08-23
- **Target enrollment:** 249 (ACTUAL)
- **Last updated:** 2025-02-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05065658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05065658, "Posaconazole Prophylaxis for CAPA Prevention in Critically-Ill Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05065658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*